Indivior Pharmaceuticals (INDV) Selling, General & Administrative (2024 - 2026)
Indivior Pharmaceuticals (INDV) recorded Selling, General & Administrative of $122 million in Q2 2026, down 22.8% from $158 million a year earlier and down 1.6% from the prior quarter.
Powered by 
Analysis
Indivior Pharmaceuticals (INDV) Selling, General & Administrative (2024 - 2026) Analysis & Trends
On a TTM basis, Indivior Pharmaceuticals' Selling, General & Administrative came in at $590 million as of Jun 30, 2026, down 3.0% year-over-year; for FY2025, it came in at $634 million, up 3.6% from FY2024.
- Annual Selling, General & Administrative has increased for four straight years, with a four-year compound annual growth rate of 10.1% (FY2021 to FY2025).
- Across earlier years, Selling, General & Administrative came in at $612 million in FY2024 (+8.3%), $565 million in FY2023 (+21.2%), $466 million in FY2022 (+8.1%) and $431 million in FY2021.
- The Q2 2026 figure is the lowest quarterly Selling, General & Administrative in data going back to Q1 2024.
- On a year-over-year basis, Selling, General & Administrative rose in three of the last six quarters, with an average decline of 2.6%.
- Per Business Quant, the preceding three quarters came in at $124 million (Q1 2026), $189 million (Q4 2025) and $155 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Indivior Pharmaceuticals | 4.18 Bn | 3.14 Bn | 294.00 Mn | 122.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 122.00 Mn |
| Mar 31, 2026 | 124.00 Mn |
| Dec 31, 2025 | 189.00 Mn |
| Sep 30, 2025 | 155.00 Mn |
| Jun 30, 2025 | 158.00 Mn |
| Mar 31, 2025 | 133.00 Mn |
| Dec 31, 2024 | 175.00 Mn |
| Sep 30, 2024 | 142.00 Mn |
| Jun 30, 2024 | 152.00 Mn |
| Mar 31, 2024 | 143.00 Mn |
API Access
Indivior Pharmaceuticals Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=INDV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "INDV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=INDV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();